---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-097949"
form_type: "8-K"
ticker: "CHRS"
cik: "0001512762"
company_name: "Coherus Oncology, Inc."
filed_at: "2026-08-17T21:27:41+00:00"
generated_at: "2026-08-17T21:30:11.859330+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Coherus closes $55M Innovatus term loan, repays prior 8%+SOFR facility due 2029

## Summary
- Drew full $55M Tranche A on Aug 14, 2026; matures Aug 2031; rate 4.15% + greater of Prime or 6.75%.
- Proceeds repaid prior senior secured facility (8.0% + 3-mo SOFR, due May 2029); remainder for working capital.
- Interest-only for 36 months, extendable to 48 months upon revenue and market-cap milestones.
- Optional tranches: $25M Term B (milestone-gated) and $20M Term C (lender discretion).
- Prepayment fee 5% declining to 0% after year 3; final fee 4% (10% if DIP financing); facility fee 1.5%.

## SEC filing metadata
- accession: 0001104659-26-097949
- form_type: 8-K
- ticker: CHRS
- cik: 0001512762
- company_name: Coherus Oncology, Inc.
- filed_at: 2026-08-17T21:27:41+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512762/000110465926097949/0001104659-26-097949-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512762/000110465926097949/chrs-20260817x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-097949
- JSON: https://secwatch.observer/filing/0001104659-26-097949.json
- Plain text: https://secwatch.observer/filing/0001104659-26-097949.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.